HA Paired with Antioxidants for Treatment of CMV-Induced Sensorineural Hearing Loss

AJAS · 2019 Biomedical and Health Sciences (inferred)

Overview

Cytomegalovirus (CMV) is the leading non-genetic cause of sensorineural hearing loss (SNHL) in children in the United States. Current antiviral treatments exist, however with only modest short-term improvements and uncertain long-term outcome as well as reports of complications. Because CMV causes SNHL through inflammation and oxidation of the inner ear, an anti-inflammatory compound such as hyaluronic acid (HA) can be modified and combined with an antioxidant compound like D-methionine as a potential treatment. Preliminary results indicate successful synthesis of the compound CMHA+D-methionine as well as demonstrated cytocompatibility. Upcoming procedures will include testing the combined anti-inflammatory and antioxidant effects of the novel compound CMHA+D-methionine and investigating its potential to act as an effective treatment for CMV SNHL.

Competition history

  • AJAS 2019 Category not listed

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Browse more like this

Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. An account also raises your daily allowance for “Has this been done?”, and lets you create a key for the MCP server with a much higher limit than anonymous use. Browsing stays public.

Continue with Google